These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 33653635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
    James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P, Hughes A, Pope A, Nanton V, Mintz HP, Knight A, Gallagher J, Bryan RT.
    Health Technol Assess; 2024 Aug; 28(42):1-65. PubMed ID: 39246267
    [Abstract] [Full Text] [Related]

  • 3. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Panebianco V.
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [Abstract] [Full Text] [Related]

  • 7. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative.
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JWF, Panebianco V.
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [Abstract] [Full Text] [Related]

  • 11. Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
    Roumiguié M, Wong A, Belanger E, Wang G, Black PC.
    Urol Oncol; 2023 May; 41(5):254.e9-254.e15. PubMed ID: 36566105
    [Abstract] [Full Text] [Related]

  • 12. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Miyake M, Nishimura N, Inoue T, Suzuki S, Fujii T, Owari T, Hori S, Nakai Y, Toritsuka M, Nakagawa H, Tsukamoto S, Anai S, Torimoto K, Yoneda T, Tanaka N, Fujimoto K.
    Trials; 2021 Feb 12; 22(1):136. PubMed ID: 33579327
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial Protocol.
    Del Giudice F, Vestri A, Fegatelli DA, Hüsch T, Belsey J, Nair R, Skinner EC, Chung BI, Pecoraro M, Sciarra A, Franco G, Pradere B, Gazzaniga P, Magloicca FM, Panebianco V, De Berardinis E.
    BJU Int; 2024 Oct 13. PubMed ID: 39397266
    [Abstract] [Full Text] [Related]

  • 17. A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer.
    Asad D, Styrke J, Hagsheno M, Johansson M, Huge Y, Svensson J, Pelander S, Lauer J, Netterling H, Aljabery F, Sherif A.
    Scand J Urol; 2022 Feb 13; 56(1):20-26. PubMed ID: 34806518
    [Abstract] [Full Text] [Related]

  • 18. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L, Chen Y, Xu H, Xie H, Yao J, Liu J, Song B.
    Eur Radiol; 2022 Sep 13; 32(9):6480-6492. PubMed ID: 35362750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer.
    Atta MA, Kotb AF, Sharafeldeen M, Elabbady A, Hashad MM.
    Arab J Urol; 2017 Mar 13; 15(1):60-63. PubMed ID: 28275520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.